Research published in JAMA Internal Medicine reveals statins may reduce liver cancer risk by 33% and liver complications by ...
People who used lipophilic (fat-soluble) statins like atorvastatin and simvastatin had the greatest outcomes and ...
HealthDay News — For patients with chronic liver disease, statin use is associated with a reduced risk for hepatocellular carcinoma (HCC) and hepatic decompensation, according to a study published ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Harvard Medical School researchers have found that statin use significantly reduces the risk of hepatocellular carcinoma (HCC ...
Resmetirom offers a targeted approach to metabolic dysfunction–associated steatohepatitis (MASH) for use alongside lifestyle ...
Direct-acting antivirals (DAAs) have dramatically changed the landscape of chronic hepatitis C virus (HCV) treatment and ...
A comprehensive study shows that people with fatty liver disease have almost twice the mortality rate of the general population. They have an increased risk of dying from both liver diseases and ...
Inclusion of female and Hispanic/Latino patients has increased over time, but most trials of metabolic dysfunction-associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback